Karyopharm Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 5.27, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Average collection period, for Karyopharm Therapeutics Inc 's accounts receivable remained unchanged at 69 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 43 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 487 to 493.

What is Receivable Turnover Ratio?
What is Karyopharm Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KPTI Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-9.29 %	-33.73 %	-14.91 %	0.31 %	-13.33 %
Y / Y Revenue Change	-11.86 %	16.83 %	11.58 %	13.57 %	-11.35 %
Receivable Turnover Ratio (TTM)	5.27	5.29	4.63	4.36	4.2
KPTI's Total Ranking	# 493	# 487	# 475	# 2640	# 2079
Accounts Receivable average collection period days	69	69	79	84	87
Seq. Receivable Change	27.89 %	-10.78 %	-17.88 %	-3.2 %	-6.56 %
Seq. Revenue Change	-4.66 %	2.9 %	-22.63 %	16.12 %	26.37 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 11
Healthcare Sector	# 44
Overall Market	# 493

Receivable Turnover Ratio Statistics
High	Average	Low
1.37	0.51	0
(Mar 31 2026)		(Jun 30 2017)

KPTI Company Profile • Back to KPTI Efficiency Comparisons • Compare KPTI Receivables Turnover Ratio to its Competitors

Financial Statements
Karyopharm Therapeutics Inc 's Accounts Receivable	$ 30 Millions	Visit KPTI's Balance sheet
Karyopharm Therapeutics Inc 's Sales TTM	$ 147 Millions	Visit KPTI's Income Statement
Sources of KPTI's Revenues		Visit KPTI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KPTI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KPTI's Growth Rates	KPTI's Roa	KPTI's Inventory Turnover Ratio	KPTI's Dividend Comparisons
KPTI's Profitability Ratios	KPTI's Roi	KPTI's Asset Turnover Ratio	KPTI's Dividend Growth
KPTI's Valuation Ratios	KPTI's Roe	KPTI's Financial Strength Ratios	KPTI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Skinhealth Systems Inc	13.04	$ 289.224 Millions	$ 22.179 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Teladoc Health Inc	11.74	$ 2,489.480 Millions	$ 212.023 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Irhythm Holdings Inc	10.32	$ 825.702 Millions	$ 80.007 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions

Date modified: 2026-09-03T11:56:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.